NRIX logo

NRIX
Nurix Therapeutics Inc

641
Mkt Cap
$1.66B
Volume
1.16M
52W High
$22.50
52W Low
$8.20
PE Ratio
-5.07
NRIX Fundamentals
Price
$16.03
Prev Close
$16.24
Open
$16.30
50D MA
$15.75
Beta
1.61
Avg. Volume
1.25M
EPS (Annual)
-$3.05
P/B
3.45
Rev/Employee
$264,921.14
$995.06
Loading...
Loading...
News
all
press releases
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 85.8% in Nurix Therapeutics (NRIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Nurix Therapeutics' (NRIX) "Buy" Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed a "buy" rating and set a $32.00 target price on shares of Nurix Therapeutics in a research note on Friday...
MarketBeat·1d ago
News Placeholder
Nurix Therapeutics (NASDAQ:NRIX) Price Target Cut to $28.00 by Analysts at Wells Fargo & Company
Wells Fargo & Company lowered their price target on Nurix Therapeutics from $29.00 to $28.00 and set an "overweight" rating on the stock in a research report on Thursday...
MarketBeat·2d ago
News Placeholder
Company News for Apr 9, 2026
Companies in The News Are: DAL,RPM,NRIX,LEVI
Zacks·2d ago
News Placeholder
Needham & Company LLC Reaffirms "Buy" Rating for Nurix Therapeutics (NASDAQ:NRIX)
Needham & Company LLC restated a "buy" rating and set a $26.00 price objective on shares of Nurix Therapeutics in a report on Wednesday...
MarketBeat·3d ago
News Placeholder
Nurix Therapeutics (NASDAQ:NRIX) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS
Nurix Therapeutics (NASDAQ:NRIX - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.79) earnings per share for the quarter, missing the consensus estimate of...
MarketBeat·3d ago
News Placeholder
Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates
Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of -4.22% and -57.21%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
Nurix Therapeutics Posts Wider Loss In Q1
(RTTNews) - Nurix Therapeutics, Inc. (NRIX) reported a first quarter net loss of $87.2 million or $0.79 per share compared with a net loss of $56.4 million or $0.67 per share, prior year. Revenue was...
Nasdaq News: Markets·3d ago
News Placeholder
Nurix Therapeutics (NRIX) Expected to Announce Quarterly Earnings on Tuesday
Nurix Therapeutics (NASDAQ:NRIX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, April 14. (View Earnings Report at...
MarketBeat·5d ago
News Placeholder
Nurix Therapeutics (NASDAQ:NRIX) Trading 7.3% Higher - Still a Buy?
Nurix Therapeutics (NASDAQ:NRIX) Trading Up 7.3% - Time to Buy...
MarketBeat·5d ago
<
1
2
...
>

Latest NRIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.